KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other Working Capital Changes (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Other Working Capital Changes for 17 consecutive years, with -$1.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 47.31% to -$1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$471.0 million, a 24.52% increase, with the full-year FY2025 number at -$471.0 million, up 24.52% from a year prior.
  • Other Working Capital Changes was -$1.1 billion for Q4 2025 at Bristol Myers Squibb, down from -$240.0 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.1 billion in Q1 2022 to a low of -$1.1 billion in Q4 2025.
  • A 5-year average of $22.3 million and a median of -$170.0 million in 2023 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 185.27% in 2022, then plummeted 383.05% in 2024.
  • Bristol Myers Squibb's Other Working Capital Changes stood at -$272.0 million in 2021, then plummeted by 157.35% to -$700.0 million in 2022, then surged by 59.57% to -$283.0 million in 2023, then plummeted by 156.18% to -$725.0 million in 2024, then plummeted by 47.31% to -$1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Other Working Capital Changes are -$1.1 billion (Q4 2025), -$240.0 million (Q3 2025), and -$222.0 million (Q2 2025).